StockData
iBio, Inc. logo

iBio, Inc. (IBIO) stock

IBIONasdaqPharmaceutical PreparationsFiscal year ends June 30
Financials through Q1 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 9/30
$0.85+0.10 (+13.37%)

Close on Nov 18, 2026Market cap $54.54MP/E –Yield –

iBio market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

iBio's market cap was $45.91M on Nov 11, 2026, against $24.91M a year earlier. Over the last 5 years it ranged from $1.56M to $119.83M, with a median of $22.34M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$45.91M+17.4%
2025Dec 31, 2025$39.09M+84.7%
2024Dec 31, 2024$21.16M+1017.2%
2023Dec 29, 2023$1.89M-52.2%
2022Dec 30, 2022$3.96M-96.7%
2021Dec 31, 2021$119.83M-36.7%
2020Dec 31, 2020$189.33M+3035.6%
2019Dec 31, 2019$6.04M-56.1%
2018Dec 31, 2018$13.75M-17.7%
2017Dec 29, 2017$16.71M-53.1%
2016Dec 30, 2016$35.64M-17.7%
2015Dec 31, 2015$43.30M-7.0%
2014Dec 31, 2014$46.55M+141.5%
2013Dec 31, 2013$19.27M-34.9%
2012Dec 31, 2012$29.61M+10.2%
2011Dec 30, 2011$26.88M–

More iBio figures

See a number that looks wrong?